InspireMD Files 8-K on Financials
Ticker: NSPR · Form: 8-K · Filed: May 14, 2024 · CIK: 1433607
| Field | Detail |
|---|---|
| Company | Inspiremd, INC. (NSPR) |
| Form Type | 8-K |
| Filed Date | May 14, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, sec-filing
TL;DR
InspireMD dropped an 8-K detailing financials - check it for the latest numbers.
AI Summary
InspireMD, Inc. filed an 8-K on May 14, 2024, reporting on its results of operations and financial condition, as well as financial statements and exhibits. The filing details the company's status as a Delaware corporation with its principal executive offices located in Tel Aviv, Israel.
Why It Matters
This 8-K filing provides crucial updates on InspireMD's financial performance and condition, which is essential information for investors and stakeholders to assess the company's current health and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not appear to contain any immediate or significant new risks.
Key Numbers
- 001-35731 — Commission File Number (Identifies the company's filing with the SEC.)
- 26-2123838 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- InspireMD, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of Incorporation
- Tel Aviv, Israel (location) — Principal Executive Offices
- Saguaro Resources, Inc. (company) — Former Company Name
FAQ
What specific financial information is being reported in this 8-K?
The filing indicates it pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits', but the specific details of these are not provided in the header information.
When was the earliest event reported in this filing?
The earliest event reported is May 14, 2024, which is also the date of the report.
What was InspireMD, Inc. formerly known as?
InspireMD, Inc. was formerly known as Saguaro Resources, Inc.
What is the primary business of InspireMD, Inc. based on its SIC code?
InspireMD, Inc.'s SIC code is 3841, which corresponds to 'SURGICAL & MEDICAL INSTRUMENTS & APPARATUS'.
Where are InspireMD, Inc.'s principal executive offices located?
InspireMD, Inc.'s principal executive offices are located at 4 Menorat Hamaor St., Tel Aviv, Israel.
Filing Stats: 526 words · 2 min read · ~2 pages · Grade level 12 · Accepted 2024-05-14 07:10:30
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share NSPR The Nasdaq Capital M
Filing Documents
- form8-k.htm (8-K) — 36KB
- ex99-1.htm (EX-99.1) — 88KB
- ex99-1_001.jpg (GRAPHIC) — 3KB
- 0001493152-24-019080.txt ( ) — 306KB
- nspr-20240514.xsd (EX-101.SCH) — 3KB
- nspr-20240514_lab.xml (EX-101.LAB) — 33KB
- nspr-20240514_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INSPIREMD, INC. Date: May 14, 2024 By: /s/ Craig Shore Name: Craig Shore Title: Chief Financial Officer